
Sign up to save your podcasts
Or


Interim results from the previously paused trial suggest that doses of the experimental gene therapy drug GTX-102 are well tolerated in children with the autism-linked condition.
By The Transmitter4.4
1919 ratings
Interim results from the previously paused trial suggest that doses of the experimental gene therapy drug GTX-102 are well tolerated in children with the autism-linked condition.

43,837 Listeners

7,913 Listeners

8,801 Listeners

1,993 Listeners

544 Listeners

429 Listeners

183 Listeners

10 Listeners

113,121 Listeners

56,944 Listeners

6,592 Listeners

5,576 Listeners

29,272 Listeners

16,525 Listeners

1,600 Listeners

9 Listeners

747 Listeners